NextFin

ARKK Sells $9.8M in Tempus AI and $6.8M in CRISPR, Boosts AMD and Beam by $7.5M Each

Summarized by NextFin AI
  • On April 12, 2026, ARK Innovation ETF (ARKK) made significant reallocations, reducing holdings in Tempus AI Inc-A and CRISPR Therapeutics AG, while increasing stakes in Advanced Micro Devices Inc and Beam Therapeutics Inc.
  • ARKK's net sell of approximately $9.8 million in Tempus AI Inc-A and $6.8 million in CRISPR Therapeutics AG reflects a strategic portfolio adjustment.
  • Increased investments in Advanced Micro Devices Inc by over $7.5 million and Beam Therapeutics Inc by $7.4 million indicate confidence in tech and biotech sectors.
  • Overall, ARK's trading activity demonstrates a focus on high-potential innovation sectors while managing risks by trimming positions in less favorable stocks.

ARKK Daily Position Changes Report: April 11 to April 12, 2026

Overview

On April 12, 2026, the ARK Innovation ETF (ARKK) exhibited a balanced trading session with significant reallocations across several major holdings. Key transactions involved reductions in Tempus AI Inc-A and CRISPR Therapeutics AG positions, while increased stakes were notable in Advanced Micro Devices Inc and Beam Therapeutics Inc. The trading activity reflects ARK's adaptive portfolio management in response to changing market conditions and company outlooks.

Detailed Summary

Detailed analysis of ARKK's daily activity shows a net sell of approximately $9.8 million in Tempus AI Inc-A, indicating a strategic reduction. Similarly, CRISPR Therapeutics AG saw a decrease of around $6.8 million. Conversely, ARK increased its exposure in Advanced Micro Devices Inc by over $7.5 million and Beam Therapeutics Inc by approximately $7.4 million, signaling confidence in these growth-oriented technology and biotech names. Other decreases include Shopify Inc-A, Robinhood Markets Inc-A, and Coinbase Global Inc-A, collectively reducing exposure by nearly $14.8 million. Notable buys included Roku Inc-A and Tesla Inc, adding $4.1 million and $1.2 million respectively. The net reallocation points to ARK's focus on high-potential innovation sectors while trimming positions where valuations or outlooks warrant caution.

Analysis and Interpretation

ARKK’s buy and sell decisions on April 12, 2026, illustrate a tactical portfolio rotation. The sell-offs in Tempus AI Inc-A and CRISPR Therapeutics AG may reflect profit-taking or a recalibration of risk exposures in the biotech segment. Meanwhile, increased investments into Advanced Micro Devices Inc and Beam Therapeutics Inc suggest confidence in semiconductor and gene-editing technology trends. The reduction in positions like Shopify and Robinhood could be attributed to market volatility or shifts in e-commerce and fintech outlooks. Overall, ARK continues to align its holdings with its innovation-driven investment philosophy by adjusting weights to leverage growth opportunities while managing portfolio risk.

Position Changes Table

Ticker Company Name Direction Estimated Trade Value ($) % of Portfolio Change
TEM Tempus AI Inc-A Sell -9,799,352.58 -0.1521
AMD Advanced Micro Devices Inc Buy 7,534,225.44 0.1371
BEAM Beam Therapeutics Inc Buy 7,413,407.09 0.1329
CRSP CRISPR Therapeutics AG Sell -6,778,120.68 -0.0968
CRCL None Buy 6,358,434.94 0.1161
SHOP Shopify Inc-A Sell -5,751,889.98 -0.0850
HOOD Robinhood Markets Inc-A Sell -5,434,254.37 -0.0799
ROKU Roku Inc-A Buy 4,074,140.57 0.0782
COIN Coinbase Global Inc-A Sell -3,598,577.19 -0.0497
TSLA Tesla Inc Buy 1,219,063.34 0.0445

Explore more exclusive insights at nextfin.ai.

Insights

What are the core principles guiding ARK's investment strategy?

How did ARK Innovation ETF originate and what is its purpose?

What trends are currently influencing the ARK Innovation ETF market?

What feedback have users provided regarding ARK's portfolio performance?

What recent changes have occurred in ARK's holdings as of April 2026?

Which policies may affect the future operations of ARK Innovation ETF?

How might ARK's investment approach evolve over the next few years?

What long-term impacts could ARK's recent trades have on its portfolio?

What challenges does ARK face in maintaining its innovative investment philosophy?

Which controversies surround ARK's trading strategies and decisions?

How does ARK's performance compare to other similar ETFs in the market?

What historical cases illustrate ARK's adaptive portfolio management?

How have competitor ETFs responded to ARK's investment strategies?

What specific technologies is ARK betting on for future growth?

How significant are the reductions in Tempus AI and CRISPR positions?

What factors contribute to ARK's decision to increase exposure in AMD and Beam?

What lessons can investors learn from ARK's recent trading decisions?

What role does market volatility play in ARK's investment decisions?

How does ARK manage risks associated with its high-tech investments?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App